Rituximab induced cytokine release syndrome in an MS patient: A case report

Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear.

Detalles Bibliográficos
Autores principales: Etemadifar, Masoud, Salari, Mehri, Saeri, Mahdieh, Sigari, Amirhossein Akhavan, Ebrahimi Pelarti, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271264/
https://www.ncbi.nlm.nih.gov/pubmed/34267900
http://dx.doi.org/10.1002/ccr3.4407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271264/
https://www.ncbi.nlm.nih.gov/pubmed/34267900
http://dx.doi.org/10.1002/ccr3.4407

Ejemplares similares